KIR2DL1 and vitiligo: It has been known for almost 30 years that there is an increase in circulating NK cells in the blood of vitiligo patients with abnormalities in their expression of inhibitory receptor CD158a and their activity (44–47), yet their role in vitiligo skin remained unexplored until recently.